Science & Technology
MiDROPS® Achieves Pivotal Milestone: Confirmed Stable and Effective in Allotment II Clinical Trial
EyeCRO's MiDROPS® platform demonstrates safety and efficacy in Phase II clinical trials, offering potential breakthrough for dry eye disease treatment with implications for global…